A Retrospective Analysis of Raltegravir Use in Minority HIV Infected Women in Houston, Texas
Information source: The University of Texas Health Science Center, Houston
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: HIV Infection
Intervention: raltegravir (Drug)
Phase: N/A
Status: Active, not recruiting
Sponsored by: The University of Texas Health Science Center, Houston
Summary
Raltegravir is the first marketed strand-transfer inhibitor of HIV-1 that was FDA approved
in 2007. It is currently one of the preferred treatment regimens for HIV by the Department
of Health and Human Services. It has become a widely used antiretroviral therapy option for
HIV infected patients. It provides good tolerability and a favorable lipid profile for
patients when compared to some other antiretroviral treatment options. Little data is
reported about efficacy in a minority patient population. Moreover, data in an indigent
minority population in the United States has not been aggregated before. Therefore this
study will investigate the efficacy of raltegravir in minority women residing in Houston, TX
who are HIV infected.
Clinical Details
Official title: A Retrospective Analysis of Raltegravir Use in Minority HIV Infected Women in Houston, Texas
Study design: Time Perspective: Retrospective
Primary outcome: Assess the efficacy of raltegravir in study participants by measuring CD4 count and viral load
Secondary outcome: Capture data on concomitant conditions that may have led to participants switching to raltegravir from medical records (eg. Diabetes mellitus)Assess tolerability of raltegravir by capturing symptoms
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Female.
Criteria:
Inclusion Criteria:
1. HIV-infected women who picked up raltegravir in the year 2013 at Thomas Street Health
Center.
2. Minority women - Black/African American, Hispanic/Latino
Exclusion Criteria:
- n/a
Locations and Contacts
Thomas Street Clinic, Houston, Texas 77009, United States
Additional Information
Starting date: September 2014
Last updated: July 24, 2015
|